These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20835517)

  • 1. Monoclonal gammopathy associated with visceral leishmaniasis.
    Sharma V; Agarwal MP; Giri S
    Braz J Infect Dis; 2010; 14(3):297-8. PubMed ID: 20835517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 3. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of sodium stibogluconate and rifampicin in post kala-azar dermal leishmaniasis.
    Sharma VK; Prasad HR; Sethuraman G; Khaitan BK
    Indian J Dermatol Venereol Leprol; 2007; 73(1):53-4. PubMed ID: 17314452
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
    Collini P; Premchand N; Lockwood D; Greig J
    Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal gammopathy in human leishmaniasis.
    Randi ML; Ruzzon E; Tezza F; Tezza F; Pacquola E; Fabris F
    Neth J Med; 2006 Feb; 64(2):50-1. PubMed ID: 16517989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 9-year-old with fever and severe muscle pains.
    Punda-Polić V; Bradarić N; Grgić D
    Lancet; 1997 Jun; 349(9066):1666. PubMed ID: 9186386
    [No Abstract]   [Full Text] [Related]  

  • 9. Sodium stibogluconate.
    Shrestha NK
    Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
    Kumar D; Ramesh V; Verma S; Ramam M; Salotra P
    Ann Trop Med Parasitol; 2009 Dec; 103(8):727-30. PubMed ID: 20030997
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
    Wkly Epidemiol Rec; 2017 Sep; 92(35):566-72. PubMed ID: 28945058
    [No Abstract]   [Full Text] [Related]  

  • 12. Visceral leishmaniasis presenting as generalized lymphadenopathy in Nepal.
    Sah SP; Raj GA; Kalra OP; Ansari JA
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):36-7. PubMed ID: 10695785
    [No Abstract]   [Full Text] [Related]  

  • 13. [A difficult diagnosis?].
    Kager PA
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1217-20. PubMed ID: 2991785
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral leshmaniasis diagnosed on duodenal biopsy in a child.
    Boukthir S; Mejri A; M'rad S; Barsaoui S
    Acta Gastroenterol Belg; 2003; 66(3):258-9. PubMed ID: 14618961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
    Sharma RK; Jha R; Kumar P; Kher V; Gupta A; Kumar A; Gulati S; Arora P; Murari M; Bhandari M
    Am J Nephrol; 1996; 16(4):358-60. PubMed ID: 8739293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis.
    Moore EM; Lockwood DN
    Clin Med (Lond); 2011 Oct; 11(5):492-7. PubMed ID: 22034715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.